Truist cuts Fresenius Medical Care price target to $24
Truist Securities lowered its Fresenius Medical Care price target to $24 from $25 per share, Newsmetry API reported, citing Benzinga analyst data.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Truist Securities reduced its price target for Fresenius Medical Care to $24 per share from the previous $25. Newsmetry API reported the change, citing Benzinga data.
The information appears in Benzinga’s section covering analyst ratings for FMS.
why it matters
A revised price target signals a change in analysts’ valuation of Fresenius Medical Care and may be considered by the market when assessing the shares.
instruments
sources
- Fresenius Medical Care Price Target Cut to $24.00/Share From $25.00 by Truist Securities — Newsmetry API, 12 October 2026 at 18:25 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗